+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Allergy Diagnostics and Therapeutics Market Forecast to 2033- Product Image
Allergy Diagnostics and Therapeutics Market Forecast to 2033- Product Image
New

Allergy Diagnostics and Therapeutics Market Forecast to 2033

  • PDF Icon

    Report

  • 150 Pages
  • October 2025
  • Region: Global
  • Grand View Research
  • ID: 4827936
REQUEST CUSTOMIZATION
Description Jump to:
The global allergy diagnostics and therapeutics market size was estimated at USD 34.42 billion in 2024 and is projected to reach USD 78.00 billion by 2033, growing at a CAGR of 9.7% from 2025 to 2033. Some of the major factors driving the market are rising incidence of allergies, advancements in technology and launch of new products, and high adoption of immunotherapy drugs.

In November 2022, the Global Allergy and Airways Patient Platform reported that approximately 30-40% of people today have one or more allergies, and the number of people with allergies has been increasing over the past 20 years. Furthermore, changing lifestyle and growing pollution are some of the key factors contributing to the increasing incidence of allergic conditions. The introduction of therapeutically advanced drugs namely immunotherapy, which solves unmet patient needs, is expected to boost market growth over the forecast period. For instance, in February 2024, the U.S. Food and Drug Administration approved Xolair (omalizumab) injection for immunoglobulin E-mediated food allergy in certain adults and children 1 year or older for the reduction of allergic reactions (Type I), including reducing the risk of anaphylaxis, that may occur with accidental exposure due to more than one food. Also, Xolair is intended for repeated use to reduce the risk of allergic reactions and is not approved for the immediate emergency treatment of allergic reactions, including anaphylaxis.

The rising prevalence of allergies is one of the important reasons driving the growth of the allergy therapeutics market over the predicted period. High risk factors for chronic respiratory disorders include increased exposure to outdoor and indoor air pollution, as well as occupational exposure. Allergies are far more common in cities than in rural areas, owing to increased exposure to environmental contaminants due to industrial activity and urbanization.

According to statistics published by WHO in January 2024, around 1 in 4 children and 1 in 3 adults have a seasonal allergy in the U.S. Nearly 6% of children and adults in the U.S. suffer from a food allergy, with the rate being highest among black, Asian, and Hispanic individuals. Similarly, as per data from the Asthma and Allergy Foundation of America, in 2021, in the U.S., about 81 million people were diagnosed with seasonal allergic rhinitis, representing around 26% affected adults and 19% affected children.

Increasing demand for IVD testing is likely to drive the allergy diagnostics and therapeutics market over the forecast period. In vitro blood tests are used to diagnose food, inhalation, skin, and medication allergies. These tests have several advantages, including the fact that they are minimally invasive, cost-effective, and user-friendly, which is expected to provide profitable growth prospects in this market. Furthermore, the development of low-cost and effective in vitro diagnostic tests for allergy detection, increased lab automation, and an increase in reagent rental agreements are all projected to contribute to market expansion in the future years.

Global Allergy Diagnostics and Therapeutic Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2030. For this report, the analyst has segmented the global allergy diagnostics & therapeutics market based on type, allergen type, test type, and region:

Type Outlook (Revenue, USD Million, 2021-2033)

  • Diagnostics
  • Therapeutics

Allergen Type Outlook (Revenue, USD Million, 2021-2033)

  • Food
  • Inhaled
  • Drug
  • Others allergen types

Test Type Outlook (Revenue, USD Million, 2021-2033)

  • In Vivo Tests
  • In Vitro Tests

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Report Deliverables

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Allergy Diagnostics and Therapeutics Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product Method
1.1.1.2. Allergen Type Segment
1.1.1.3. Test Type Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Allergy Diagnostics and Therapeutics Market: Executive Summary
2.1. Market Snapshot
2.2. Product Snapshot
2.3. Allergen Type Snapshot
2.4. Type Snapshot
2.5. Competitive Landscape Snapshot
Chapter 3. Allergy Diagnostics and Therapeutics Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Rising incidence of allergies
3.4.2. Advancements in technology and launch of new products
3.4.3. High adoption of immunotherapy drugs
3.5. Market Restraint Analysis
3.5.1. Low adoption and penetration in developing countries due to the high cost of technology
3.5.2. Lack of allergen standardization
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis
Chapter 4. Allergy Diagnostics and Therapeutics Market: Type Estimates & Trend Analysis
4.1. Allergy Diagnostics and Therapeutics Market: Test Method Movement Analysis
4.2. Diagnostics
4.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3. Instruments
4.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4. Consumables
4.4.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Services
4.5.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Therapeutics
4.6.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.7. Antihistamines
4.7.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.8. Decongestants
4.8.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.9. Corticosteroids
4.9.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.10. Mast Cell Stabilizers
4.10.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.11. Leukotriene Inhibitors
4.11.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.12. Nasal Anti-cholinergic
4.12.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.13. Immuno-modulators
4.13.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.14. Epinephrine
4.14.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.15. Immunotherapy
4.15.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Allergy Diagnostics and Therapeutics Market: Allergen Type Estimates & Trend Analysis
5.1. Allergy Diagnostics and Therapeutics Market: Mode Movement Analysis
5.2. Food
5.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.3. Dairy Products
5.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4. Poultry Product
5.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Tree Nuts
5.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Peanuts
5.6.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.7. Shellfish
5.7.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.8. Wheat
5.8.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.9. Soy
5.9.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.10. Other Food Allergens
5.10.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.11. Inhaled
5.11.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.12. Drug
5.12.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.13. Others allergen types
5.13.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Allergy Diagnostics and Therapeutics Market: Test Type Estimates & Trend Analysis
6.1. Allergy Diagnostics and Therapeutics Market: Type Movement Analysis
6.2. in Vivo tests
6.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.3. Skin Prick Test
6.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.4. Intradermal Test
6.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Patch Test
6.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.6. in Vitro tests
6.6.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Allergy Diagnostics and Therapeutics Market: Regional Business Analysis
7.1. Regional Market Snapshot
7.2. North America
7.2.1. North America Allergy Diagnostics and Therapeutics Market Estimates and Forecast, 2021-2033 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.2.2.2. Key Country Dynamics
7.2.2.3. Regulatory Framework
7.2.2.4. Reimbursement Scenario
7.2.2.5. Competitive Scenario
7.2.3. Canada
7.2.3.1. Canada Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.2.3.2. Key Country Dynamics
7.2.3.3. Regulatory Framework
7.2.3.4. Reimbursement Scenario
7.2.3.5. Competitive Scenario
7.2.4. Mexico
7.2.4.1. Mexico Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.2.4.2. Key Country Dynamics
7.2.4.3. Regulatory Framework
7.2.4.4. Reimbursement Scenario
7.2.4.5. Competitive Scenario
7.3. Europe
7.3.1. Europe Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.3.2. UK
7.3.2.1. UK Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.3.2.2. Key Country Dynamics
7.3.2.3. Regulatory Framework
7.3.2.4. Reimbursement Scenario
7.3.2.5. Competitive Scenario
7.3.3. Germany
7.3.3.1. Germany Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.3.3.2. Key Country Dynamics
7.3.3.3. Regulatory Framework
7.3.3.4. Reimbursement Scenario
7.3.3.5. Competitive Scenario
7.3.4. Spain
7.3.4.1. Spain Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.3.4.2. Key Country Dynamics
7.3.4.3. Regulatory Framework
7.3.4.4. Reimbursement Scenario
7.3.4.5. Competitive Scenario
7.3.5. France
7.3.5.1. France Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.3.5.2. Key Country Dynamics
7.3.5.3. Regulatory Framework
7.3.5.4. Reimbursement Scenario
7.3.5.5. Competitive Scenario
7.3.6. Italy
7.3.6.1. Italy Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.3.6.2. Key Country Dynamics
7.3.6.3. Regulatory Framework
7.3.6.4. Reimbursement Scenario
7.3.6.5. Competitive Scenario
7.3.7. Denmark
7.3.7.1. Denmark Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.3.7.2. Key Country Dynamics
7.3.7.3. Regulatory Framework
7.3.7.4. Reimbursement Scenario
7.3.7.5. Competitive Scenario
7.3.8. Sweden
7.3.8.1. Sweden Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.3.8.2. Key Country Dynamics
7.3.8.3. Regulatory Framework
7.3.8.4. Reimbursement Scenario
7.3.8.5. Competitive Scenario
7.3.9. Norway
7.3.9.1. Norway Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.3.9.2. Key Country Dynamics
7.3.9.3. Regulatory Framework
7.3.9.4. Reimbursement Scenario
7.3.9.5. Competitive Scenario
7.4. Asia-Pacific
7.4.1. Asia-Pacific Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.4.2. Japan
7.4.2.1. Japan Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.4.2.2. Key Country Dynamics
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Scenario
7.4.2.5. Competitive Scenario
7.4.3. China
7.4.3.1. China Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.4.3.2. Key Country Dynamics
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Scenario
7.4.3.5. Competitive Scenario
7.4.4. India
7.4.4.1. India Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.4.4.2. Key Country Dynamics
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Scenario
7.4.4.5. Competitive Scenario
7.4.5. South Korea
7.4.5.1. South Korea Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.4.5.2. Key Country Dynamics
7.4.5.3. Regulatory Framework
7.4.5.4. Reimbursement Scenario
7.4.5.5. Competitive Scenario
7.4.6. Thailand
7.4.6.1. Thailand Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.4.6.2. Key Country Dynamics
7.4.6.3. Regulatory Framework
7.4.6.4. Reimbursement Scenario
7.4.6.5. Competitive Scenario
7.4.7. Australia
7.4.7.1. Australia Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.4.7.2. Key Country Dynamics
7.4.7.3. Regulatory Framework
7.4.7.4. Reimbursement Scenario
7.4.7.5. Competitive Scenario
7.5. Latin America
7.5.1. Latin America Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.5.2.2. Key Country Dynamics
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Scenario
7.5.2.5. Competitive Scenario
7.5.3. Argentina
7.5.3.1. Argentina Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.5.3.2. Key Country Dynamics
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Scenario
7.5.3.5. Competitive Scenario
7.6. MEA
7.6.1. MEA Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.6.2.2. Key Country Dynamics
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Scenario
7.6.2.5. Competitive Scenario
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.6.3.2. Key Country Dynamics
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Scenario
7.6.3.5. Competitive Scenario
7.6.4. UAE
7.6.4.1. UAE Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.6.4.2. Key Country Dynamics
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Scenario
7.6.4.5. Competitive Scenario
7.6.5. Kuwait
7.6.5.1. Kuwait Allergy Diagnostics and Therapeutics Market, 2021-2033 (USD Million)
7.6.5.2. Key Country Dynamics
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Scenario
7.6.5.5. Competitive Scenario
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.2.1. New Product Launch
8.2.2. Partnerships
8.2.3. Acquisition
8.2.4. Collaboration
8.2.5. Funding
8.3. Key Company Market Share Analysis, 2024
8.4. Company Heat Map Analysis
8.5. Company Profiles
8.5.1. R-Biopharm AG
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer, Inc.)
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. DASIT Group SPA
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. AESKU.GROUP GmbH
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. bioMérieux
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Danaher
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. AbbVie, Inc
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Thermo Fisher Scientific, Inc
8.5.8.1. Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Stallergenes Greer
8.5.9.1. Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Minaris Medical America, Inc.
8.5.10.1. Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
8.5.11. Siemens Healthcare GmbH
8.5.11.1. Overview
8.5.11.2. Financial Performance
8.5.11.3. Product Benchmarking
8.5.11.4. Strategic Initiatives
8.5.12. Omega Diagnostics Group PLC
8.5.12.1. Overview
8.5.12.2. Financial Performance
8.5.12.3. Product Benchmarking
8.5.12.4. Strategic Initiatives
8.5.13. HYCOR Biomedical
8.5.13.1. Overview
8.5.13.2. Financial Performance
8.5.13.3. Product Benchmarking
8.5.13.4. Strategic Initiatives
8.5.14. Lincoln Diagnostics, Inc.
8.5.14.1. Overview
8.5.14.2. Financial Performance
8.5.14.3. Product Benchmarking
8.5.14.4. Strategic Initiatives
8.5.15. Alcon
8.5.15.1. Overview
8.5.15.2. Financial Performance
8.5.15.3. Product Benchmarking
8.5.15.4. Strategic Initiatives
8.5.16. HOB Biotech Group Corp., Ltd.
8.5.16.1. Overview
8.5.16.2. Financial Performance
8.5.16.3. Product Benchmarking
8.5.16.4. Strategic Initiatives
8.5.17. AbbVie Inc.
8.5.17.1. Overview
8.5.17.2. Financial Performance
8.5.17.3. Product Benchmarking
8.5.17.4. Strategic Initiatives
8.5.18. Allergy Therapeutics
8.5.18.1. Overview
8.5.18.2. Financial Performance
8.5.18.3. Product Benchmarking
8.5.18.4. Strategic Initiatives
8.5.19. Sanofi
8.5.19.1. Overview
8.5.19.2. Financial Performance
8.5.19.3. Product Benchmarking
8.5.19.4. Strategic Initiatives
8.5.20. Pfizer Inc.
8.5.20.1. Overview
8.5.20.2. Financial Performance
8.5.20.3. Product Benchmarking
8.5.20.4. Strategic Initiatives
8.5.21. Teva Pharmaceutical Industries Ltd.
8.5.21.1. Overview
8.5.21.2. Financial Performance
8.5.21.3. Product Benchmarking
8.5.21.4. Strategic Initiatives
8.5.22. Sun Pharmaceutical Industries Ltd.
8.5.22.1. Overview
8.5.22.2. Financial Performance
8.5.22.3. Product Benchmarking
8.5.22.4. Strategic Initiatives
8.5.23. GSK plc
8.5.23.1. Overview
8.5.23.2. Financial Performance
8.5.23.3. Product Benchmarking
8.5.23.4. Strategic Initiatives
8.5.24. F. Hoffmann-La Roche Ltd.
8.5.24.1. Overview
8.5.24.2. Financial Performance
8.5.24.3. Product Benchmarking
8.5.24.4. Strategic Initiatives
8.5.25. Merck & Co., Inc.
8.5.25.1. Overview
8.5.25.2. Financial Performance
8.5.25.3. Product Benchmarking
8.5.25.4. Strategic Initiatives
8.5.26. Astellas Pharma Inc.
8.5.26.1. Overview
8.5.26.2. Financial Performance
8.5.26.3. Product Benchmarking
8.5.26.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Allergy Diagnostics & Therapeutics Market, by Region, 2021-2033 (USD Million)
Table 4 Global Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 5 Global Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 6 Global Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 7 North America Allergy Diagnostics & Therapeutics Market, by Country, 2021-2033 (USD Million)
Table 8 North America Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 9 North America Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 10 North America Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 11 U.S. Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 12 U.S. Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 13 U.S. Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 14 Canada Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 15 Canada Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 16 Canada Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 17 Europe Allergy Diagnostics & Therapeutics Market, by Country, 2021-2033 (USD Million)
Table 18 Europe Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 19 Europe Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 20 Europe Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 21 UK Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 22 UK Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 23 UK Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 24 Germany Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 25 Germany Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 26 Germany Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 27 France Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 28 France Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 29 France Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 30 Italy Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 31 Italy Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 32 Italy Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 33 Spain Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 34 Spain Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 35 Spain Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 36 Denmark Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 37 Denmark Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 38 Denmark Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 39 Sweden Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 40 Sweden Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 41 Sweden Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 42 Norway Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 43 Norway Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 44 Norway Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 45 Asia-Pacific Allergy Diagnostics & Therapeutics Market, by Country, 2021-2033 (USD Million)
Table 46 Asia-Pacific Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 47 Asia-Pacific Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 48 Asia-Pacific Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 49 Japan Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 50 Japan Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 51 Japan Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 52 China Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 53 China Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 54 China Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 55 India Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 56 India Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 57 India Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 58 Australia Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 59 Australia Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 60 Australia Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 61 South Korea Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 62 South Korea Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 63 South Korea Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 64 Thailand Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 65 Thailand Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 66 Thailand Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 67 Latin America Allergy Diagnostics & Therapeutics Market, by Country, 2021-2033 (USD Million)
Table 68 Latin America Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 69 Latin America Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 70 Latin America Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 71 Brazil Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 72 Brazil Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 73 Brazil Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 74 Mexico Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 75 Mexico Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 76 Mexico Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 77 Argentina Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 78 Argentina Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 79 MEA Allergy Diagnostics & Therapeutics Market, by Country, 2021-2033 (USD Million)
Table 80 MEA Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 81 MEA Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 82 MEA Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 83 South Africa Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 84 South Africa Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 85 South Africa Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 86 Saudi Arabia Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 87 Saudi Arabia Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 88 Saudi Arabia Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 89 UAE Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 90 UAE Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 91 UAE Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
Table 92 Kuwait Allergy Diagnostics & Therapeutics Market, by Type, 2021-2033 (USD Million)
Table 93 Kuwait Allergy Diagnostics & Therapeutics Market, by Allergen type, 2021-2033 (USD Million)
Table 94 Kuwait Allergy Diagnostics & Therapeutics Market, by Test Type, 2021-2033 (USD Million)
List of Figures
Figure 1 Allergy Diagnostics & Therapeutics Market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modelling for market share assessment.
Figure 8 Market formulation & validation
Figure 9 Allergy Diagnostics & Therapeutics Market snapshot
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook.
Figure 12 Penetration and growth prospect mapping
Figure 13 Allergy Diagnostics & Therapeutics Market driver impact
Figure 14 Allergy Diagnostics & Therapeutics Market restraint impact
Figure 15 SWOT analysis, by factor (political & legal, economic, and technological)
Figure 16 Industry Analysis - Porter's
Figure 17 Strategy mapping
Figure 18 Allergy Diagnostics & Therapeutics Market: Type outlook and key takeaways
Figure 19 Allergy Diagnostics & Therapeutics Market: Type movement analysis & market share 2024 & 2030
Figure 20 Diagnostics Market estimates and forecast, 2021-2033 (USD Million)
Figure 21 Therapeutics Market estimates and forecast, 2021-2033 (USD Million)
Figure 22 Instruments market estimates and forecast, 2021-2033 (USD Million)
Figure 23 Consumable market estimates and forecast, 2021-2033 (USD Million)
Figure 24 Services market estimates and forecast, 2021-2033 (USD Million)
Figure 25 Antihistamines Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021-2033 (USD Million)
Figure 26 Angiotensin 2 Receptor Blockers Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021-2033 (USD Million)
Figure 27 Decongestants Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021-2033 (USD Million)
Figure 28 Corticosteroids Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021-2033 (USD Million)
Figure 29 Mast Cell Stabilizers Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021-2033 (USD Million)
Figure 30 Leukotriene Inhibitors Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021-2033 (USD Million)
Figure 31 Nasal Anti-cholinergic Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021-2033 (USD Million)
Figure 32 Immuno-modulators Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021-2033 (USD Million)
Figure 33 Epinephrine Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021-2033 (USD Million)
Figure 34 Immunotherapy Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021-2033 (USD Million)
Figure 35 Allergy Diagnostics & Therapeutics Market: Allergen Type outlook and key takeaways
Figure 36 Allergy Diagnostics & Therapeutics Market: Allergen Type movement analysis & market share 2024 & 2030
Figure 37 Food market estimates and forecast, 2021-2033 (USD Million)
Figure 38 Dairy Products market estimates and forecast, 2021-2033 (USD Million)
Figure 39 Poultry Product market estimates and forecast, 2021-2033 (USD Million)
Figure 40 Tree Nuts market estimates and forecast, 2021-2033 (USD Million)
Figure 41 Peanuts market estimates and forecast, 2021-2033 (USD Million)
Figure 42 Shellfish market estimates and forecast, 2021-2033 (USD Million)
Figure 43 Wheat market estimates and forecast, 2021-2033 (USD Million)
Figure 44 Soy market estimates and forecast, 2021-2033 (USD Million)
Figure 45 Other Food Allergens market estimates and forecast, 2021-2033 (USD Million)
Figure 46 Inhaled market estimates and forecast, 2021-2033 (USD Million)
Figure 47 Drug market estimates and forecast, 2021-2033 (USD Million)
Figure 48 Others market estimates and forecast, 2021-2033 (USD Million)
Figure 49 Allergy Diagnostics & Therapeutics Market: Test Type outlook and key takeaways
Figure 50 Allergy Diagnostics & Therapeutics Market: Test Type movement analysis & market share 2024 & 2030
Figure 51 in vivo Test market estimates and forecast, 2021-2033 (USD Million)
Figure 52 Skin Prick Test market estimates and forecast, 2021-2033 (USD Million)
Figure 53 Intradermal Test market estimates and forecast, 2021-2033 (USD Million)
Figure 54 Patch Test market estimates and forecast, 2021-2033 (USD Million)
Figure 55 in Vitro Test market estimates and forecast, 2021-2033 (USD Million)
Figure 56 Regional marketplace: Key takeaways
Figure 57 Global Allergy Diagnostics and Therapeutics Market: Regional movement analysis
Figure 58 U.S. market estimates and forecast, 2021-2033 (USD Million)
Figure 59 Canada market estimates and forecast, 2021-2033 (USD Million)
Figure 60 Europe market estimates and forecast, 2021-2033 (USD Million)
Figure 61 UK market estimates and forecast, 2021-2033 (USD Million)
Figure 62 Germany market estimates and forecast, 2021-2033 (USD Million)
Figure 63 France market estimates and forecast, 2021-2033 (USD Million)
Figure 64 Italy market estimates and forecast, 2021-2033 (USD Million)
Figure 65 Spain market estimates and forecast, 2021-2033 (USD Million)
Figure 66 Denmark market estimates and forecast, 2021-2033 (USD Million)
Figure 67 Sweden market estimates and forecast, 2021-2033 (USD Million)
Figure 68 Norway market estimates and forecast, 2021-2033 (USD Million)
Figure 69 Asia-Pacific market estimates and forecast, 2021-2033 (USD Million)
Figure 70 Japan market estimates and forecast, 2021-2033(USD Million)
Figure 71 China market estimates and forecast, 2021-2033 (USD Million)
Figure 72 India market estimates and forecast, 2021-2033 (USD Million)
Figure 73 South Korea market estimates and forecast, 2021-2033 (USD Million)
Figure 74 Australia market estimates and forecast, 2021-2033 (USD Million)
Figure 75 Thailand market estimates and forecast, 2021-2033 (USD Million)
Figure 76 Latin America market estimates and forecast, 2021-2033 (USD Million)
Figure 77 Brazil market estimates and forecast, 2021-2033 (USD Million)
Figure 78 Mexico market estimates and forecast, 2021-2033 (USD Million)
Figure 79 Argentina market estimates and forecast, 2021-2033 (USD Million)
Figure 80 MEA market estimates and forecast, 2021-2033 (USD Million)
Figure 81 South Africa market estimates and forecast, 2021-2033 (USD Million)
Figure 82 Saudi Arabia market estimates and forecast, 2021-2033 (USD Million)
Figure 83 UAE market estimates and forecast, 2021-2033 (USD Million)
Figure 84 Kuwait market estimates and forecast, 2021-2033 (USD Million)
Figure 85 Strategy framework

Companies Mentioned

The companies profiled in this Allergy Diagnostics and Therapeutics market report include:
  • R-Biopharm AG
  • R-Biopharm AG
  • DASIT Group SPA
  • EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer, Inc.)
  • AESKU.GROUP GmbH
  • bioMérieux
  • Siemens Healthcare GmbH
  • Stallergenes Greer
  • HYCOR Biomedical
  • Minaris Medical America, Inc.
  • Omega Diagnostics Group PLC
  • Lincoln Diagnostics, Inc.
  • HOB Biotech Group Corp., Ltd.
  • Danaher
  • Alcon
  • AbbVie, Inc.
  • Sanofi
  • Allergy Therapeutics
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • GSK plc
  • Sun Pharmaceutical Industries Ltd
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Astellas Pharma Inc.
  • Epigenomics AG

Table Information

Report AttributeDetails
No. of Pages150
PublishedOctober 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 34.42 Billion
Forecasted Market Value ( USD ) by 2033 $ 78 Billion
Compound Annual Growth Rate9.7%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Allergy Diagnostic & Treatment Market - Global Forecast 2025-2030 - Product Image

Allergy Diagnostic & Treatment Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Allergy Diagnostics Market Size, Share & Trends Analysis Report By Products And Services (Instruments, Consumables), By Allergen (Food, Inhaled, Drugs), By Test Type (In Vivo Test, In Vitro Test), By End Use (Hospital & Clinics), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Allergy Diagnostics Market Size, Share & Trends Analysis Report By Products And Services (Instruments, Consumables), By Allergen (Food, Inhaled, Drugs), By Test Type (In Vivo Test, In Vitro Test), By End Use (Hospital & Clinics), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 320 Pages
  • Global
From
Allergy Diagnostics - Global Strategic Business Report - Product Image

Allergy Diagnostics - Global Strategic Business Report

  • Report
  • 638 Pages
  • Global
From
Global Markets for Allergy Diagnostics and Treatments - Product Image

Global Markets for Allergy Diagnostics and Treatments

  • Report
  • 194 Pages
  • Global
From
Food Allergy Diagnostics & Therapeutics Market - Global Forecast 2025-2032 - Product Image

Food Allergy Diagnostics & Therapeutics Market - Global Forecast 2025-2032

  • Report
  • 191 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.